Affordable Access

Publisher Website

Frequency of PositiveXmnIGγ polymorphism and coinheritance of common alpha thalassemia mutations do not show statistically significant difference between thalassemia major and intermedia cases with homozygous IVSII-1 mutation

Authors
Journal
Blood Cells Molecules and Diseases
1079-9796
Publisher
Elsevier
Publication Date
Volume
44
Issue
2
Identifiers
DOI: 10.1016/j.bcmd.2009.10.007
Keywords
  • Thalassemia Major
  • Thalassemia Intermedia
  • Alpha Thalassemia
  • Genetic Modifiers
  • Xmngγ Polymorphism
Disciplines
  • Biology
  • Medicine

Abstract

Abstract From 362 thalassemia cases referred to adult thalassemia clinic of the Iranian blood transfusion organization (IBTO) for genotyping, 103 cases (28.5%) had a common primary disease factor, IVSII-1 mutation in homozygous state. 61 (59.2%) of these individuals represented thalassemia major and 42 (40.8%) thalassemia intermedia clinical phenotype. To re-evaluate our current diagnostic criteria, XmnI Gγ polymorphism and coexistence of alpha thalassemia mutations, frequently recalled as important factors modifying the clinical phenotype of homozygous beta zero thalassemia cases in our country, were examined in both groups. No statistically significant difference in the frequency of positive XmnI Gγ polymorphism was observed between thalassemia intermedia and thalassemia major patients. Double gene deletion -- Med was observed in only one thalassemia major case, while − a 3.7 in heterozygous state (− a 3.7/aa) was identified in 6 (9.8%) of thalassemia major and 8 (19%) of thalassemia intermedia patients. − a 4.2 was observed in only one thalassemia major case. No statistically significant difference in the frequency of coinheritance of alpha thalassemia was observed between the two groups. These results imply that other interacting mechanisms which modify the phenotype of thalassemia patients is still in the dark in our current diagnostic criteria of thalassemia.

There are no comments yet on this publication. Be the first to share your thoughts.